Sironax
The Regulatory and Study Start-Up Specialist leads and coordinates regulatory and study start-up activities for clinical trials across Australia and New Zealand, supporting site activation from feasibility through initiation. This role ensures all regulatory, ethics, governance, contractual, and operational requirements are completed in compliance with applicable regulations and company procedures. The position requires close collaboration with Clinical Operations, Project Management, investigators, ethics committees, and regulatory authorities to facilitate efficient study start-up.
Sironax is a biopharmaceutical company committed to developing transformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases. The company targets underlying contributors of aging and degeneration — including disrupted energy homeostasis, dysregulated cell death, and uncontrolled inflammation — across various organs and tissues. Its pipeline includes first-in-class and best-in-class small molecule and large molecule programs, with clinical-stage assets such as a SARM1 inhibitor and a NAMPT activator.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sironax.
Sironax didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role